Pridinol Methanesulfonate Salt

Pridinol Methanesulfonate Salt Structure
Pridinol Methanesulfonate Salt structure
Common Name Pridinol Methanesulfonate Salt
CAS Number 6856-31-1 Molecular Weight 391.52400
Density N/A Boiling Point 585.1ºC at 760 mmHg
Molecular Formula C21H29NO4S Melting Point 152.5-155ºC
MSDS Chinese USA Flash Point 307.6ºC
Symbol GHS07
GHS07
Signal Word Warning

Anticataleptic effect of taurine: interaction with antiparkinsonian agents.

Pol. J. Pharmacol. Pharm. 39(4) , 329-35, (1987)

The influence of taurine on cataleptogenic effect of neuroleptics was investigated in male Wistar rats. It was found that taurine 900 micrograms/rat icv reduced significantly haloperidol or fluphenazine-induced catalepsy. In rats receiving taurine in a dose o...

Suicide by multidrug ingestion: hypothesis on the role played by the self-administration of activated charcoal.

Am. J. Forensic Med. Pathol. 28(1) , 55-8, (2007)

A fatal suicidal ingestion of drugs, together with activated charcoal, is reported. The death occurred 31 hours after the self-administration. The autopsy revealed a large amount of gastric content that appeared to be a compact mass of black color. Toxicologi...

Pridinolum mesylate and neuroleptic malignant syndrome.

Am. J. Psychiatry 142(3) , 389-90, (1985)

Assessing treatment of neuroleptic malignant syndrome.

Am. J. Psychiatry 143(1) , 120-1, (1986)

Effect of muscle relaxants on experimental jaw-muscle pain and jaw-stretch reflexes: a double-blind and placebo-controlled trial.

Eur. J. Pain 7(5) , 449-56, (2003)

A randomised, double-blind, placebo-controlled three-way cross-over study was performed to investigate the effect of two muscle relaxants (tolperisone hydrochloride and pridinol mesilate) on experimental jaw-muscle pain and jaw-stretch reflexes. Fifteen healt...

[Possibility of occurrence of psychoses after pridinol treatment].

Psychiatr. Pol. 14(1) , 88-9, (1980)

[More about antiparkinson agents].

Psychiatr. Pol. 15(3) , 329, (1981)

[Topical therapy of musculo-articular diseases with a drug combination].

Clin. Ter. 101(2) , 143-9, (1982)

[Clinical study of a drug combination in the treatment of metarheumatic and metatraumatic disorders].

Clin. Ter. 101(3) , 267-74, (1982)

[Comparison of systemic and local therapy in rheumatic myalagia and arthralgia].

Clin. Ter. 99(3) , 305-12, (1981)